Previous Article | Next Article ![]()
Journal of Bacteriology, October 2002, p. 5234-5239, Vol. 184, No. 19
0021-9193/02/$04.00+0 DOI: 10.1128/JB.184.19.5234-5239.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Nara Figueroa-Bossi,2 Minhua Wang,1 Sergio Uzzau,2,
Lionello Bossi,2 and James M. Slauch1,3*
Department of Microbiology,1 College of Medicine, University of Illinois, Urbana, Illinois 61801,3 Centre de Genetique, Centre National de la Recherche Scientifique, 91198 Gif-sur-Yvette, France2
Received 23 April 2002/ Accepted 2 July 2002
|
|
|---|
|
|
|---|
Most, if not all, isolates of S. enterica serovar Typhimurium are lysogens of bacteriophage Gifsy-2 (9), which is a lambdoid bacteriophage having the same relative gene order as the prototype phage
. S. enterica serovar Typhimurium strains cured of Gifsy-2 are significantly attenuated in the mouse (8), indicating that Gifsy-2 contributes virulence factors to its host. One of these factors is SodCI, a periplasmic Cu/Zn superoxide dismutase (5, 6) that presumably protects the bacteria against superoxide produced by macrophages (6). S. enterica serovar Typhimurium strains with mutant sodCI are attenuated in macrophages as well as in mice (5). Gifsy-2 also carries the unusual gene grvA. Mutations in grvA increase virulence as measured in a competition assay. This so-called antivirulence phenotype is absolutely dependent on sodCI, suggesting that GrvA is also involved in SodCI-mediated resistance to phagocytic superoxide (15).
It is clear that Gifsy-2 contributes more than sodCI to virulence in S. enterica serovar Typhimurium lysogens (8, 15). Based on sequence analysis and other evidence, there are several candidates for the additional virulence determinant(s) carried by Gifsy-2 (Fig. 1). The putative product of gtgA is 75% identical to PipA, encoded on Salmonella pathogenicity island 5 (SPI-5) (18). S. enterica serovar Dublin strains with mutant pipA showed reduced fluid secretion and intestinal inflammation in a bovine-ileal-loop model (28). These mutants were unaffected in the mouse model of systemic infection (28). Interestingly, the Gifsy-1 lambdoid phage carries a gene, gogA, which is essentially identical in sequence and relative position to Gifsy-2 gtgA (10). Upstream of sodCI is the ailT gene, whose product has homology to the Lom/Ail family of proteins (10). In S. enterica serovar Typhimurium, other members of this family include PagC, involved in macrophage survival (1, 23) (39% identical to AilT) and Rck, which is encoded by the virulence plasmid and which confers serum resistance (14) (35% identical to AilT). The sseI/sfrH gene is under the control of SsrAB, a two-component regulatory system encoded on SPI-2, and is transcriptionally induced in macrophages (29). The SseI protein is secreted into the eukaryotic cell cytoplasm by the SPI-2 type III secretion system (20). The role of sseI/srfH in an animal infection has not been previously reported. The gtgF gene, proximal to attR, is predicted to encode a small 63-amino-acid protein that is 76% identical to that encoded by msgA. A mutation in the msgA gene increased the intraperitoneal (i.p.) 50% lethal dose of S. enterica serovar Typhimurium 300-fold and attenuated the strain in macrophage survival assays (11). A second MsgA homolog, SrfE (48% identical to GtgF) was identified as the product of an SsrAB-regulated gene (29).
![]() View larger version (18K): [in a new window] |
FIG. 1. Gene organization of the Gifsy-2 bacteriophage. Data were from reference 18 and our laboratories. (Top) Open reading frames with identifiable orthologs in phage lambda are labeled. Most of these genes are termed gft (Gifsy-2), e.g., gftO. White arrows, putative virulence genes; gray arrows, putative phage genes; lines, deletion intervals. (Bottom) Gene organization of the B region. Genes with no obvious role in phage production are termed gtg (Gifsy-2 gene) (10).
|
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. S. enterica serovar Typhimurium strains
|
Red recombinase.
Insertion/deletion mutations in Gifsy-2 were constructed via the
Red recombinase method (4, 30) using constructs developed by Datsenko and Wanner (4). PCR primers of 50 to 60 nucleotides (nt) were synthesized with 30 to 40 nt on the 5' ends corresponding to the ends of the desired deletion. The 3' 20 nt of each primer anneal to plasmids pKD3 and pKD4 or to pKD13 at the 5' or 3' end of an antibiotic resistance cassette flanked by FRT sites for Flp-mediated recombination (4). PCRs were carried out according to the manufacturer's instructions (Invitrogen, Carlsbad, Calif.). Plasmid pKD46 was introduced into S. enterica serovar Typhimurium strain 14028. This plasmid synthesizes the
recombination proteins Gam, Bet, and Exo when induced with arabinose (1 mM). The plasmid-bearing strain was grown at 30°C in LB medium-AP-1 mM arabinose and was made electrocompetent (16). Approximately 800 ng of PCR product was transformed, and the cells were plated on LB medium containing the appropriate antibiotic and incubated at 37°C. This generally resulted in 30 to 50 antibiotic-resistant colonies, representing Red-mediated integration of the cassette by homologous recombination with the 30- to 40-bp ends of the PCR fragment. Each insertion/deletion mutation was characterized by genetic mapping and PCR. The insertions/deletions were transduced via P22 to construct isogenic strains for subsequent analysis. The precise endpoints of the deletions are indicated in Table 1. Removal of antibiotic cassettes using Flp recombinase. A temperature-sensitive plasmid carrying the Flp recombinase (pCP20) (2) was transformed into strains containing the insertion/deletion mutations. The resulting transformed colonies were restreaked twice in the presence of AP at 30°C to select for the plasmid. Flp mediates site-specific recombination between the FRT sites that flank the antibiotic resistance cassette, resulting in loss of the marker. The strains were then restreaked on LB agar at 37 to 42°C twice. The resulting strains were checked for loss of the temperature-sensitive plasmid and the antibiotic resistance cassette.
Virulence assays. Strains were grown overnight in LB broth at 37°C with aeration and washed once in an equal volume of 0.15 M NaCl. For each experiment, the two strains of interest were mixed 1:1 and the mixture was diluted in 0.15 M NaCl. Female BALB/c mice (Harlan Sprague-Dawley, Inc., Indianapolis, Ind., or Iffa-Credo, Lyon, France) approximately 6 weeks old were inoculated with the mixture, containing 200 to 2,000 bacterial cells. Inocula were plated on LB plates and then replica plated onto appropriate selective media to determine the total number and percentage of bacteria from each inoculated strain. In some cases, one of the two strains was marked with a chromosomal ara-lac operon fusion (araD901::MudJ) to simplify screening. This fusion was verified not to have any effect on the ability of S. enterica serovar Typhimurium to infect mice (see Table 3).
|
View this table: [in a new window] |
TABLE 3. Competition assays with gtgE and gtgE+ complemented strainsa
|
In vitro growth assays. Equal volumes of overnight LB cultures of mutant and wild-type bacteria were mixed, washed, diluted, and inoculated into glucose NCE medium (200 to 400 bacteria into 5 ml). Each inoculum was plated on laboratory media to precisely determine the number of bacteria and the percentage of the mutant in the mixture. After 24 h growth at 37°C with aeration, cultures were diluted in saline and plated on laboratory media. The percentages of mutant bacteria recovered were analyzed as in the in vivo competition assays.
|
|
|---|
Red recombinase method (4, 30) and determined the virulence of these deletion strains in competition assays after i.p. injection. First, a strain with the entire Gifsy-2 phage and its proposed attachment sites deleted was competed against the isogenic wild-type strain. The virulence of the
Gifsy-2::Km (JS223) strain was attenuated >100-fold with respect to the wild-type strain (Table 2), consistent with previous data (8, 15). This decrease in virulence was much greater than the sixfold attenuation conferred by a sodCI insertion (Table 2). Therefore, Gifsy-2 must contribute some other virulence determinant(s) in addition to sodCI. |
View this table: [in a new window] |
TABLE 2. Competition assays with Gifsy-2 deletion strains
|
Based on sequence analysis, one possible candidate for the additional Gifsy-2 virulence factor was ailT, a gene whose presumed product is homologous to several serum resistance proteins (10). To determine if ailT contributes to virulence, we constructed a null mutation in the gene. The ailT insertion/deletion mutant competed evenly against an isogenic wild-type strain in an i.p. competition assay (Table 2). This showed that the ailT gene did not have a significant effect on virulence during i.p. infection of BALB/c mice.
In phage
, genes located between phage gene J and attR, termed the B region, are not necessary for the production of viable phage (3). To further delineate the location of additional virulence genes on the Gifsy-2 phage, we deleted the analogous B region of the Gifsy-2 phage (Fig. 1) and inserted a kanamycin resistance cassette, designating the mutation
(G-2 B). The Gifsy-2 B region deletion mutant (JS159) was ninefold attenuated compared to the wild type (Table 2). This suggested that the Gifsy-2 B region contained a virulence gene(s) that contributes to the attenuation of a strain cured of the Gifsy-2 phage.
Previously identified genes in the B region have no effect on virulence in the whole animal. Recently, it has been shown that sseI/sfrH, located in the B region, is transcriptionally induced in macrophages (29) and encodes a protein that is secreted by the SPI-2 type III secretion system (20). We tested whether this gene was responsible for the contribution of the B region to virulence. A deletion of stfT through sseI (Fig. 1) was constructed, and the mutant strain (JS229) was tested for virulence in competition assays against the wild type (14028). We found that the deletion mutant competed evenly with the wild type (Table 2). Thus, none of the genes in this interval were responsible for the contribution of the B region to virulence. Although sseI is induced within a macrophage and the resulting protein is secreted into the cytoplasm of eukaryotic cells, loss of this product does not significantly affect S. enterica serovar Typhimurium virulence in BALB/c mice after i.p. inoculation.
Identification of the gtgE virulence gene.
The above results indicated that the virulence determinant in the B region was located downstream of sseI. This was confirmed by deleting genes gtgC through attR (Fig. 1). The resulting strain (JS230) was attenuated to approximately the same degree as the
(G-2 B) strain (Table 2). We then constructed deletions in the four major open reading frames in this region, gtgC, gtgD, gtgE, and gtgF. Strain JS221, with the gtgE and gtgF open reading frames deleted, was attenuated to the same extent as the
(G-2 B) strain (Table 2). Deletion of gtgC, gtgD, or gtgF had no significant effect on virulence (Table 2). These results indicate that gtgE is the primary virulence determinant in this region. This was confirmed by assaying a strain with a deletion of only gtgE; MA7073 is attenuated to the same extent as the
gtgEF mutant. The fact that insertions/deletions in either the upstream or downstream open reading frames have no effect suggests that gtgE is transcribed independently of gtgF and gtgD.
To determine whether the virulence phenotypes observed in vivo were due to general growth defects, an assay involving competition between the
gtgEF mutant and the wild type in minimal medium was performed. There was no significant difference between the mutant and wild type after overnight growth (median CI = 0.83; n = 6). Indeed, deletion of the entire Gifsy-2 phage did not affect growth of S. enterica serovar Typhimurium in minimal medium (median CI = 0.94; n = 6).
Complementation of the gtgE virulence gene.
To ensure that the observed phenotype is due to loss of gtgE function, a wild-type copy of the gtgE gene was cloned in either orientation onto plasmid pNFB9, which contains the attachment site and the int gene of bacteriophage Gifsy-1. Expression of Gifsy-1 integrase causes the plasmid to integrate via site-specific recombination at the Gifsy-1 attachment site (attG1) in S. enterica serovar Typhimurium. (Loss of the Gifsy-1 phage does not affect virulence in i.p. infection assays [8, 25].) Strains with gtgE in Gifsy-2 deleted and containing either of the gtgE+ plasmids integrated at attG1 competed against the isogenic
gtgE strain containing the integrated vector. As shown in Table 3, the strains containing the single-copy gtgE+ plasmids behaved like the wild type in these assays. Taken together, these data indicate that the virulence defect conferred by the
(G-2 B) mutation is due to loss of gtgE function.
The gtgE and sodCI genes are the major virulence determinants carried by Gifsy-2.
The data above indicate that gtgE and sodCI are responsible for the contribution of Gifsy-2 to virulence. To explicitly test this, we constructed a sodCI gtgE double mutant and tested its virulence phenotype. Because gtgE and sodCI with deletion/insertion mutations both encoded kanamycin resistance, we used the Flp recombinase method to delete the marker cassette inserted into the gtgE deletion mutant (see Materials and Methods). The absence of the gtgE gene was confirmed by PCR. In competition assays, this
gtgEF mutant competed evenly with the original
gtgEF::Km mutant (data not shown). The double mutant was tested in competition assays against a strain with the Gifsy-2 phage deleted (JS226). The sodCI gtgE double-mutant strain outcompeted the strain with Gifsy-2 only twofold (Table 3). Given that the Gifsy-2 deletion strain is approximately 150-fold attenuated, this demonstrated that SodCI and GtgE are the major contributors to virulence encoded by Gifsy-2 in S. enterica serovar Typhimurium. However, deletion of the entire phage apparently confers an additional, but subtle, virulence defect. This could be due to an additive effect of losing several independent Gifsy-2 genes, which may include putative virulence factors, but also phage functions such as recE and the immunity region (
[attL-gftO]::Km; Table 2).
Having shown that the gtgE and sodCI genes are necessary virulence determinants carried by Gifsy-2, we tested if gtgE and sodCI genes are sufficient to complement the virulence defect due to a Gifsy-2 deletion. We cloned wild-type copies of the gtgE and the sodCI genes, separately and together, on pir-dependent plasmid pGP704 (22). The vector and resulting plasmids were each integrated at the
attachment site (as in reference 15) in strains with Gifsy-2 deleted, and the resulting strains competed against an isogenic Gifsy-2+ strain. As shown in Table 4, the
Gifsy-2 strain containing the sodCI+ plasmid resembles a
gtgE strain. Surprisingly, introduction of the gtgE+ plasmid restores virulence essentially to a wild-type level. Indeed, introduction of sodCI+ in this background does not result in any significant virulence increase. We presume that altered expression of the genes from the plasmids affects the level of complementation. However, it is clear from this data that both SodCI and GtgE contribute significantly to the virulence of S. enterica serovar Typhimurium strain 14028.
|
View this table: [in a new window] |
TABLE 4. Competition assays with complemented strains
|
|
|
|---|
Consistent with results for previous mutations that genetically separated Gifsy-2 phage production and virulence (15), two results presented here confirm that SodCI and GtgE function independently of the Gifsy-2 phage life cycle. First, the
(attL-gftO)::Km strain is fully virulent. This deletion should block Gifsy-2 excision, late gene transcription, and replication. Second, wild-type gtgE and sodCI, when separated from the phage genome, complement the virulence defect conferred by a Gifsy-2 deletion. Thus, expression and function of gtgE and sodCI are independent of Gifsy-2 phage biology. This is in contrast to what is found for some phage-produced virulence factors such as Shiga toxin 2, carried on lambdoid phages in lysogenic Shiga toxin-producing Escherichia coli strains. In these cases, toxin production is under the transcriptional control of the late operon, such that toxin is produced only when the phage is induced, killing the bacterial cell (27).
SodCI is a periplasmic Cu/Zn superoxide dismutase, important for protection of the bacterium against phagocytic superoxide in the animal (5, 6). The gtgE gene encodes a putative protein of 228 amino acids with no significant homologs in other bacterial species found in the National Center for Biotechnology Information database. The GtgE protein is acidic (pI 4.6) with no apparent N-terminal signal sequence or transmembrane domains, suggesting a cytoplasmic protein. Epitope-tagging experiments indicate that GtgE is produced by S. enterica serovar Typhimurium cells growing in vitro as well as intracellularly in HEp-2 epithelial cells (26). Thus, GtgE represents a novel bacterial virulence factor. It is formally possible that the protein is secreted, for example, by the SPI-2 type III secretion system, given that the signals for type III secretion are not easily recognized. It is also possible that GtgE is a type III chaperone. If this is true, then its target protein is not carried on Gifsy-2 or Gifsy-1. Indeed, the phenotype conferred by loss of GtgE is apparently more severe than that conferred by loss of any previously identified SPI-2 effector except SifA (24). Information regarding the biochemical function of GtgE will require further analyses.
Gifsy-2 genes with homology to known virulence factors individually had no significant effect on the virulence of S. enterica serovar Typhimurium in i.p competition assays. There are several possible explanations for these results. Perhaps some of the genes have been acquired only recently by the Gifsy-2 phage and have not evolved or adapted to the appropriate regulatory circuitry. Alternatively, the products of these genes might perform redundant functions. For example, a second, nearly identical copy of the gtgA gene of Gifsy-2 is found in the genome of the Gifsy-1 prophage. Another likely possibility is that these loci specify activities involved in aspects of infection that are not reflected in the mouse model or that are too subtle to measure in whole-animal experiments. SseI is clearly secreted into the eukaryotic cell by the SPI-2 type III secretion system (20). However, loss of SseI produced no discernible phenotype. Indeed, the lack of a significant phenotype in a mouse model is not uncommon with effector proteins (see references 13 and 21 for examples). This does not mean that these proteins do not have some role in the host, and it will be important to understand their biochemical function in order to fully understand Salmonella pathogenesis.
This work was supported by grant 00-25 to J.M.S. from the Roy J. Carver Charitable Trust and by funds to L.B. from the Centre National de la Recherche Scientifique, France.
Present address: Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, MA 02115. ![]()
Present address: Department of Biomedical Sciences University of Sassari, 07100 Sassari, Italy. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2010 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»